Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 10930012310027 | Other Identifier | ZonMw |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Capri Hartrevalidatie | UNKNOWN |
| Maxima Medical Center | OTHER |
| ZonMw: The Netherlands Organisation for Health Research and Development | OTHER |
Not provided
Not provided
Not provided
Not provided
The primary objective of this project is to investigate the effectiveness and costs of integrating a behavioural program targeting sleep and stress (the RESST intervention) into cardiac rehabilitation (CR). In addition, the investigators will also study whether parameters regarding diversity (e.g., sex, ethnicity, socioeconomic position) are associated with intervention effectiveness. Furthermore, the investigators aim to explore the (bidirectional) relation between sleep and stress on the one hand, and other lifestyle components and health outcomes on the other hand.
CR focuses on the secondary prevention of cardiovascular disease (CVD) by promoting a healthy lifestyle and is a valuable approach to improve quality of life, mortality and hospital readmissions. However, optimization of CR is necessary. Current CR programs pay insufficient attention to sleep and stress problems, despite more than 50% of CVD patients experiencing sleep problems and high stress levels. Both sleep and stress are associated with adverse cardiovascular health and a decreased quality of life. The hypothesis for this study is that adding a behavioural intervention will improve sleep and perceived stress (primary outcomes), along with positive outcomes on biomarkers of chronic stress, QoL, cardiometabolic risk factors, physical fitness, lifestyle components, and psychosocial well-being.
The project involves a multicenter randomized controlled trial. The intervention group (100 patients) will receive standard CR along with the RESST intervention, consisting of 5-6 on-site group sessions integrating principles from Acceptance and Commitment Therapy and Cognitive Behavioral Therapy and focused on improving sleep and stress. The control group (100 patients) will receive standard multidisciplinary CR only.
The primary outcomes of the study include both objective and subjective measures of sleep, as well as perceived stress. Secondary outcomes encompass quality of life, chronic stress biomarkers, cardiometabolic risk factors, physical fitness, lifestyle components and psychosocial wellbeing. These outcomes will be assessed before and after the intervention, as well as at a 6-month follow-up.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group | Experimental | The intervention group will receive standard CR along with the RESST intervention, consisting of 5 on-site group sessions, focused on sleep and stress, integrating principles from Acceptance and Commitment Therapy and Cognitive Behavioral Therapy. |
|
| Control group | No Intervention | The control group will receive standard CR only. Standard CR programs consist of 6-12 weeks of twice-weekly supervised, group-based exercise sessions. In addition, educational sessions are provided, covering topics such as medical information, cardiovascular risk factors, adopting a heart-healthy lifestyle, and coping with emotions. Depending on the patient's specific needs, counselling sessions on stress management, smoking cessation, and healthy diet are available, and individual counselling can be provided by a social worker, dietician, or psychologist/psychiatrist. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RESST | Behavioral | Subjects randomized to the RESST intervention will receive on top of standard rehabilitation a behavioural group intervention focussing on improving sleep and stress. This intervention will consist of 5 group sessions of 120 minutes each in the local rehabilitation centre. Sessions should be completed within a maximum of 4 months since the start of CR. |
| Measure | Description | Time Frame |
|---|---|---|
| Objectively assessed sleep duration | This will be measured with a GENEACTIV accelerometer for 7 days and nights continuously. | At baseline, after 3 months, and after 6 months. |
| Objectively assessed sleep-onset latency | This will be measured with a GENEACTIV accelerometer for 7 days and nights continuously. | At baseline, after 3 months, and after 6 months. |
| Objectively assessed wake after sleep onset | This will be measured with a GENEACTIV accelerometer for 7 days and nights continuously. | At baseline, after 3 months, and after 6 months. |
| Objectively assessed sleep efficiency | This will be measured with a GENEACTIV accelerometer for 7 days and nights continuously. | At baseline, after 3 months, and after 6 months. |
| Self-reported sleep quality | This will be measured with the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Score between 0-21, higher score indicates worse sleep quality. | At baseline, after 3 months, and after 6 months. |
| Perceived stress level | This will be measured with the Perceived Stress Scale-10 (PSS-10) questionnaire. Score between 0-40, higher score indicates higher perceived stress. | At baseline, after 3 months, and after 6 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Cortisol level | This will be measured by taking a hair sample. The amount of cortisol in the hair will be determined in a lab. | At baseline, after 3 months, and after 6 months. |
| Cortisone level |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nienke ter Hoeve, PhD | Contact | +31107033190 | n.terhoeve@erasmusmc.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Máxima Medisch Centrum | Recruiting | Eindhoven | North Brabant | 5631BM | Netherlands |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41991268 | Derived | van Loon I, Ooms E, Luik A, Sunamura M, Wally T, Boersma E, Vromen T, Tenbult-van Limpt N, Bussmann H, Boon M, Louter M, Redekop K, Ista E, van den Berg-Emons R, Ter Hoeve N; other OPTICARE-RESST Consortium members. Optimising sleep and managing stress by integrating a behavioural intervention during cardiac rehabilitation: rationale and design of the OPTICARE-RESST multicentre randomised controlled trial. BMJ Open. 2026 Apr 16;16(4):e117963. doi: 10.1136/bmjopen-2026-117963. |
Not provided
Not provided
Not provided
After termination of the study.
The processed data will be made available in a repository. The Principal investigator can be contacted to request access to the data. Access to the data is evaluated by the OPTICARE RESST Consortium. If allowed based on the consortium agreement and the informed consent and when the intended methodology seems suitable data can be shared after signing of a DTA. Data will be further pseudonymized before sharing.
Not provided
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Patients are randomized to treatment or control.
Not provided
Not provided
Not provided
Not provided
|
This will be measured by taking a hair sample. The amount of cortisone in the hair will be determined in a lab.
| At baseline, after 3 months, and after 6 months. |
| Weight | Weight will be measured with a digital scale in kilograms. | At baseline, after 3 months, and after 6 months. |
| Height | Height will be measured with a stadiometer in centimeters. | At baseline. |
| Body Mass Index (BMI) | Weight and height will be combined to report BMI in kg/m^2. | At baseline, after 3 months, and after 6 months. |
| Blood pressure | Blood pressure will be measured with a blood pressure monitor. | At baseline, after 3 months, and after 6 months. |
| Smoking behaviour | This will be measured with a carbon monoxide breath tester. | At baseline, after 3 months, and after 6 months. |
| Smoking behaviour | This will be measured with a self-designed questionnaire. The outcome of this questionnaire indicates whether a person smokes/has smoked in the past/does not smoke, what sort of tobacco is being smoked and how much the participant smokes. | At baseline, after 3 months, and after 6 months. |
| Muscle strength | Handgrip strength will be measured with a hand dynamometer. | At baseline, after 3 months, and after 6 months. |
| Physical activity | This will be measured with a GENEACTIV accelerometer for 7 days and nights continuously. | At baseline, after 3 months, and after 6 months. |
| Sedentary behaviour | This will be measured with a GENEACTIV accelerometer for 7 days and nights continuously. | At baseline, after 3 months, and after 6 months. |
| Alcohol use | This will be measured with the five-shot questionnaire. Score between 0-7, higher score indicates higher chance of alcohol overuse, misuse, and dependency. | At baseline, after 3 months, and after 6 months. |
| Health related quality of life | This will be measured with the MacNew questionnaire. Score between 1-7, higher score indicates higher health related quality of life. | At baseline, after 3 months, and after 6 months. |
| Health related quality of life | This will be measured with the EuroQol 5D/EQ5D questionnaire. Score between -0.446 - 1, higher score indicates a better health state. One subscale has a score between 0-100, higher score indicates better perceived health. | At baseline, after 3 months, and after 6 months. |
| Fatigue | This will be measured with the Fatigue Severity Scale (FSS) questionnaire. Score between 9-63, higher score indicates a greater fatigue severity. | At baseline, after 3 months, and after 6 months. |
| Daytime sleepiness | This will be measured with the Epworth Sleepiness Scale (ESS) questionnaire. Score between 0-24, higher score indicates a higher level of daytime sleepiness. | At baseline, after 3 months, and after 6 months. |
| Anxiety and depression | This will be measured with the Hospital Anxiety and Depression Scale (HADS) questionnaire. Score between 0-21 per subscale, higher score indicates severe symptoms of anxiety and depression. | At baseline, after 3 months, and after 6 months. |
| Participation in society | This will be measured with the USER-Participatie (USER-P) questionnare. Score between 0-100, higher score indicates higher participation in society. | At baseline, after 3 months, and after 6 months. |
| Estimated Cardiorespiratory fitness | This will be measured with the FitMáx©-Questionnaire. The outcome of this questionnaire is the estimated maximum oxygen uptake expressed in mL/kg/min. Higher score indicates better cardiorespiratory fitness. | At baseline, after 3 months, and after 6 months. |
| Presence of restless leg syndrome | This will be measured with the RLS rating scale questionnaire. Score between 0-28, higher score indicates more severe symptoms of restless leg syndrome. | At baseline. |
| Presence of insomnia | This will be measured with the Insomnia Severity Index (ISI) questionnaire. Score between 0-28, higher score indicates more severe insomnia complaints. | At baseline. |
| The risk of the presence of obstructive sleep apnoea | This will be measured with the STOP-bang questionnaire. Score between 0-8, higher score indicates higher risk of obstructive sleep apnoea. | At baseline. |
| Costs incurred by the patients | This will be measured with the IMTA Medical Consumption Questionnaire (IMCQ) which aims to determine costs within the health care system. | After 3 months and after 6 months. |
| Productivity costs | This will be measured with the IMTA Productivity Costs Questionnaire (IPCQ) which aims to determine the cost of productivity losses. | After 3 months and after 6 months. |
| Perceived sleep | This will be measured with the Sleep Consensus Diary for 7 days. The Sleep Consensus Diary consists of questions about the experience of sleep, what time the participant went to sleep, and how often the participant woke up. | At baseline, after 3 months, and after 6 months. |
| Diet | This will be measured with an electronic diary. Intake of caffeine and alcohol and timing of the main meal will be measured. | At baseline, after 3 months, and after 6 months. |
| Momentary fatigue | This will be measured with an electronic diary. | At baseline, after 3 months, and after 6 months. |
| Momentary stress | This will be measured with an electronic diary. | At baseline, after 3 months, and after 6 months. |
| Adherence to the CR treatment and RESST intervention | This will be measured by recording the number of rehabilitation components attended, such as courses on nutrition or personal counseling. | After 3 months. |
| Treatment Satisfaction | This will be measured with a self-designed questionnaire and consists of questions about the applicability, clarity and logistics of the intervention. | After 3 months. |
| Sex | Female / male / other | At baseline. |
| Age | Age in years. | At baseline. |
| Cardiac diagnosis | Cardiac diagnosis as defined by ICD-10 that has resulted in referral to cardiac rehabilitation. | At baseline. |
| Educational level | Single-item question (high, middle, or low educated). | At baseline. |
| Relational status | Single-item question. | At baseline. |
| Cardiac risk factors | Presence of cardiac risk factors (family history, diabetes mellitus, hypertension, dyslipidemia, smoking prior to event). | At baseline. |
| Cardiac history | History of cardiovascular events and diseases. | At baseline. |
| Medication usage | Number of participants using a certain type of prescribed and/or over-the-counter medication. | At baseline, after 3 months, and after 6 months. |
| Comorbidity | Presence of other diseases. | At baseline. |
| Socioeconomic status | Socioeconomic status indicated by postal code. | At baseline. |
| Origin | Determined by birth country and parents' birth country. | At baseline. |
| Employment | Determined by employment status, and type of job. | At baseline. |
| Drug use | Drug use (yes/no) and drug classification. | At baseline. |
| Current/previous sleep disorder treatment | Description of current and previous treatment for sleeping disorders. | At baseline. |
| Capri Hartrevalidatie | Recruiting | Rotterdam | South Holland | 3062MA | Netherlands |
|
| Capri Hartrevalidatie | Recruiting | The Hague | South Holland | 2597AX | Netherlands |
|